Eight members of Congress wrote to FDA Center for Veterinary Medicine director Dr. Steven Solomon this week to express concern that CVM’s GFI 256 on animal compounding may result in delayed care for veterinary patients.

“This joint letter is the culmination of the work we did at Compounders on Capitol Hill last month,” said APC Board Chair Michael Blaire. “While we would like to have seen more signatures on the letter, it’s a clear statement from members of Congress that they’re concerned about how this animal compounding GFI may interrupt animal healthcare, and they’re looking to CVM for assurances.”

The letter requests that CVM briefs members of Congress “within 60 days about how stakeholder concerns are being addressed and how the agency will implement and enforce GFI 256 in a manner that will not disrupt veterinarians’ practices and be detrimental to their patients’ health.”

APC is grateful to the following members of Congress for signing the letter: Rep. John Carter (TX), Rep. Mark Pocan (WI), Rep. Buddy Carter (GA), Rep. Bill Posey (FL), Rep. Donald Norcross (NJ), Rep. Debbie Lesko (AZ), Rep. Troy Nehls (TX), and Rep. Diana Harshbarger (TN). We’re also grateful to APC members who responded to our call to action to urge their U.S. House member to sign the letter.